Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
企業コードBHC
会社名Bausch Health Companies Inc
上場日Sep 20, 1994
最高経営責任者「CEO」Mr. Thomas J. Appio
従業員数20700
証券種類Ordinary Share
決算期末Sep 20
本社所在地2150 St. Elzear Blvd. West
都市LAVAL
証券取引所The Toronto Stock Exchange
国Canada
郵便番号H7L 4A8
電話番号18003611448
ウェブサイトhttps://www.bauschhealth.com/
企業コードBHC
上場日Sep 20, 1994
最高経営責任者「CEO」Mr. Thomas J. Appio
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし